SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277535
Filing Date
2023-11-15
Accepted
2023-11-15 07:20:29
Documents
14
Period of Report
2023-11-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850546d8k.htm   iXBRL 8-K 27997
2 EX-99.1 d850546dex991.htm EX-99.1 22330
6 GRAPHIC g850546g1115051751048.jpg GRAPHIC 2132
  Complete submission text file 0001193125-23-277535.txt   182291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20231115.xsd EX-101.SCH 2513
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20231115_lab.xml EX-101.LAB 17914
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20231115_pre.xml EX-101.PRE 11225
8 EXTRACTED XBRL INSTANCE DOCUMENT d850546d8k_htm.xml XML 3774
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 231409031
SIC: 2834 Pharmaceutical Preparations